Elevance Health, Inc. $400,000,000 5.350% Notes due 2025 $650,000,000 5.500% Notes due 2032 $750,000,000 6.100% Notes due 2052 UNDERWRITING AGREEMENTUnderwriting Agreement • November 4th, 2022 • Elevance Health, Inc. • Hospital & medical service plans • New York
Elevance Health, Inc. (f/k/a Anthem, Inc.), an Indiana corporation (the “Company”), proposes to issue and sell to the several underwriters named in Exhibit A (the “Underwriters”), acting severally and not jointly, the respective principal amounts set forth in such Exhibit A of (i) the Company’s 5.350% Notes due 2025 (the “2025 Notes”), (ii) the Company’s 5.500% Notes due 2032 (the “2032 Notes”) and (iii) the Company’s 6.100% Notes due 2052 (the “2052 Notes” and, together with the 2025 Notes and the 2032 Notes, the “Notes”), certain terms of which are set forth on Exhibit B. BofA Securities, Inc. and Deutsche Bank Securities Inc. have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Notes. Certain terms used in this Underwriting Agreement (this “Agreement”) are defined in Section 16 hereof.
